| PR B(h) --> LYS(c) (DNA binding; transregulation).
|
PR B(h) + Cdc25B(h) <==> PR B(h):Cdc25B(h) (binding)
|
PR B(h) + ATP --cyclinA(h):Cdk2(h)--> PR B(h){p} + ADP (phosphorylation)
|
Hsp90(h) + PR B(h) <==> Hsp90(h):PR B(h) (binding).
|
PR A(h) + PR B(h) <==> PR A(h):PR B(h) (binding).
|
PR B(h) + PR B(h) <==> PR B(h):PR B(h) (binding).
|
PR B(h) + TAF(II)110(d) <==> PR B(h):TAF(II)110(d) (binding).
|
PR B(h) --> IGFBP1(h) (DNA binding; transactivation).
|
PR B(h) --> GNRHR(h) (DNA binding; transregulation).
|
PR B(h) + SET-isoform2(h) <==> PR B(h):SET-isoform2(h) (binding)
|
SRC3(m.s.) + PR B(h) <==> SRC3(m.s.):PR B(h) (binding)
|
PR B(h) + DP97-xbb2(h) <==> PR B(h):DP97-xbb2(h) (binding)
|
batf3(r) + PR B(h) <==> batf3(r):PR B(h) (binding)
|
batf3(h) + PR B(h) <==> batf3(h):PR B(h) (binding)
|
jdp2(r) + PR B(h) <==> jdp2(r):PR B(h) (binding)
|
jdp2(h) + PR B(h) <==> jdp2(h):PR B(h) (binding)
|
PR B(h) --> C/EBPalpha(m) (increase of abundance)
|
PR B(h) --> Cebpa(m) (transactivation)
|
PR B(h) --/ HDAC1(m) (decrease of abundance)
|
PR B(h) + PSF(gl) <==> PR B(h):PSF(gl) (binding)
|
PSF-isoform1(h) + PR B(h) <==> PSF-isoform1(h):PR B(h) (binding)
|
PR B(h) + PSF(h) <==> PR B(h):PSF(h) (binding)
|
PR B(h) --26S proteasome(gl)--> protein remnants (degradation)
|
PR B(h) --> prl(h) (transactivation)
|
PR B(h) + NF-IL6-3(h) <==> PR B(h):NF-IL6-3(h) (binding)
|
NF-IL6-1(h) + PR B(h) <==> NF-IL6-1(h):PR B(h) (binding)
|
PR B(h) + DAX1(h) <==> PR B(h):DAX1(h) (binding)
|
PR B(h) + DAX1(h) <==> PR B(h):DAX1(h) (binding)
|
brca1(h) + PR B(h) <==> brca1(h):PR B(h) (binding)
|
PR B(h) --> c-myc(h) (DNA binding).
|
cyclinA(m.s.) + PR B(h) <==> cyclinA(m.s.):PR B(h) (binding)
|
PR B(h) + cyclinA(h) <==> PR B(h):cyclinA(h) (binding)
|
SRC-1(m.s.) + PR B(h) <==> SRC-1(m.s.):PR B(h) (binding)
|
PR B(h) + ATP --> PR B(h){pS294} + ADP (phosphorylation)
|
PR B(h) --> BCL2(h) (transactivation)
|
PR B(h) --/ Csn2(r) (DNA binding; transrepression).
|
PGR(h) --> PR B(h) (expression).
|
estradiol --> PR B(h) (increase of abundance)
|
TR2(h) --/ PR B(h) (decrease of abundance)
|
PR A(h) --> LYS(c) (DNA binding; transregulation).
|
PR A(h) + ATP --cyclinA(h):Cdk2(h)--> PR A(h){p} + ADP (phosphorylation)
|
PR A(h) + PR B(h) <==> PR A(h):PR B(h) (binding).
|
Hsp90(h) + PR A(h) <==> Hsp90(h):PR A(h) (binding).
|
PR A(h) --> IGFBP1(h) (DNA binding; transactivation).
|
PR A(h) --/ GNRHR(h) (DNA binding; transrepression).
|
batf3(r) + PR A(h) <==> batf3(r):PR A(h) (binding)
|
batf3(h) + PR A(h) <==> batf3(h):PR A(h) (binding)
|
jdp2(r) + PR A(h) <==> jdp2(r):PR A(h) (binding)
|
jdp2(h) + PR A(h) <==> jdp2(h):PR A(h) (binding)
|
TIF1a-short(h) + PR A(h) <==> TIF1a-short(h):PR A(h) (binding)
|
PSF(h) + PR A(h) <==> PSF(h):PR A(h) (binding)
|
PSF-isoform1(h) + PR A(h) <==> PSF-isoform1(h):PR A(h) (binding)
|
PR A(h) --26S proteasome(gl)--> protein remnants (degradation)
|
PR A(h) --> prl(h) (transactivation)
|
NF-IL6-3(h) + PR A(h) <==> NF-IL6-3(h):PR A(h) (binding)
|
PR A(h) + NF-IL6-1(h) <==> PR A(h):NF-IL6-1(h) (binding)
|
PR A(h) + DAX1(h) <==> PR A(h):DAX1(h) (binding)
|
PR A(h) + SMRT(h) <==> PR A(h):SMRT(h) (binding)
|
brca1(h) + PR A(h) <==> brca1(h):PR A(h) (binding)
|
PR A(h) --> c-myc(h) (DNA binding).
|
cyclinA(m.s.) + PR A(h) <==> cyclinA(m.s.):PR A(h) (binding)
|
PR A(h) + cyclinA(h) <==> PR A(h):cyclinA(h) (binding)
|
PR A(h) --> BCL2(h) (transactivation)
|
PR A(h) --/ Csn2(r) (DNA binding; transrepression).
|
PGR(h) --> PR A(h) (expression).
|
estradiol --> PR A(h) (increase of abundance)
|
TR2(h) --/ PR A(h) (decrease of abundance)
|
PR(h) + sumo1(m.s.) --> PR(h){sumoK388} (sumoylation)
|
PR(h) + MVP(h) <==> PR(h):MVP(h) (binding)
|
PR(h) + PNRC2(h) <==> PR(h):PNRC2(h) (binding)
|
PR(h) --> HLA-G(h) (DNA binding).
|
PR(h) --> BCL2(h) (DNA binding; transactivation).
|
PR(h) + HSJ2(h) <==> PR(h):HSJ2(h) (binding)
|
PR(h) + HSPA4(h) + HSJ2(h) <==> PR(h):HSPA4(h):HSJ2(h) (binding)
|
TEBP(h) + HSPA4(h) + STIP1(h) + PR(h) + Hsp90-alpha(h) <==> TEBP(h):HSPA4(h):STIP1(h):PR(h):Hsp90-alpha(h) (binding)
|
PR(h) + HSPA4(h) + Hsp40(m.s.) <==> PR(h):HSPA4(h):Hsp40(m.s.) (binding)
|
HSPA4(h) + PR(h) <==> HSPA4(h):PR(h) (binding)
|
PR(h) --> FKBP5(h) (DNA binding).
|
PGR(h) --> PR(h) (expression).
|
estradiol --> PR(h) (increase of abundance)
|
p65PAK(h) --> PR(h) (increase of abundance)
|
TR2(h) --/ PR(h) (decrease of abundance)
|
ARA70(m.s.) --> PR(h) (activation)
|
TIF2(m.s.) --> PR(h) (activation)
|
